Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolande Lievens

Showing results (71-80 of 182) with videos related to

Pageof 19
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2026
Systematic literature review of particle therapy costing: two decades of evidence on costing methods and analytical assumptionsYaqeen W Shanti, Sophie Hoozée, Delphine De Smedt, et al.
Frontiers in Public Health|January 3, 2025
Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in SpainJulieta Corral, Manel Algara, Carles Muñoz-Montplet, et al.
Physics and Imaging in Radiation Oncology|August 8, 2022
Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at riskNoémie Johnston, Jeffrey De Rycke, Yolande Lievens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 16, 2021
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO surveyDanielle Rodin, Bouchra Tawk, Osama Mohamad, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning studyYolande Lievens, An Nulens, Mousa Amr Gaber, et al.
Acta Oncologica (Stockholm, Sweden)|September 26, 2015
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?Patrick Berkovic, Leen Paelinck, Yolande Lievens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
The financial impact of SBRT for oligometastatic disease: A population-level analysis in BelgiumDaan Nevens, Isabelle Kindts, Noémie Defourny, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2002
Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trialKarin Stellamans, Yolande Lievens, Philippe Lambin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 21, 2018
Changing the global radiation therapy paradigmDavid A Pistenmaa, Manjit Dosanjh, Ugo Amaldi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2019
National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO projectNoemie Defourny, Lionel Perrier, Josep-Maria Borras, et al.
Pageof 19

Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2026
Systematic literature review of particle therapy costing: two decades of evidence on costing methods and analytical assumptionsYaqeen W Shanti, Sophie Hoozée, Delphine De Smedt, et al.
Frontiers in Public Health|January 3, 2025
Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in SpainJulieta Corral, Manel Algara, Carles Muñoz-Montplet, et al.
Physics and Imaging in Radiation Oncology|August 8, 2022
Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at riskNoémie Johnston, Jeffrey De Rycke, Yolande Lievens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 16, 2021
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO surveyDanielle Rodin, Bouchra Tawk, Osama Mohamad, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning studyYolande Lievens, An Nulens, Mousa Amr Gaber, et al.
Acta Oncologica (Stockholm, Sweden)|September 26, 2015
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?Patrick Berkovic, Leen Paelinck, Yolande Lievens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
The financial impact of SBRT for oligometastatic disease: A population-level analysis in BelgiumDaan Nevens, Isabelle Kindts, Noémie Defourny, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2002
Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trialKarin Stellamans, Yolande Lievens, Philippe Lambin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 21, 2018
Changing the global radiation therapy paradigmDavid A Pistenmaa, Manjit Dosanjh, Ugo Amaldi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2019
National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO projectNoemie Defourny, Lionel Perrier, Josep-Maria Borras, et al.
Pageof 19